Torreya
Nehal Panchal has extensive experience in financial analysis and investment banking, specializing in the healthcare and life sciences sectors. As an Associate at Stifel Financial Corp. from March 2022 to May 2024, Nehal contributed to various mergers and acquisitions, including the notable acquisition of Diurnal by Neurocrine Biosciences. Prior to this role, Nehal served as a Senior Analyst at Bank of America Continuum India Private Limited from May 2015 to March 2021, leading the delivery of financial models, valuations, and strategic opportunity analyses within the EMEA Healthcare Sector. Nehal also played a key role in mentoring new analysts and ensuring high-quality project deliverables. Nehal's career began at Bank of America with roles that included significant contributions to M&A transactions and building strong relationships with senior management in the London office. Nehal holds an MBA in Finance and a Bachelor's degree in Finance, both from the University of Mumbai.
This person is not in any offices
Torreya
Torreya, a Stifel Company, is a global investment banking boutique serving companies in the life sciences industry. Since its inception in 2007, the firm has closed over $100 billion worth of deals in nearly 250 assignments spanning branded pharmaceutical, biotechnology, generic pharmaceutical, and life sciences companies. Our partners are senior industry bankers and executives, with deep experience, knowledge, and networks. We are a partner of choice for companies seeking discreet, conflict-free and knowledgeable advice on M&A, capital markets, licensing and asset sale transactions.